Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cyclin-Dependent Kinase Inhibitor p27/*metabolism"'
Autor:
Alberto J. Arribas, Abdullah Alajati, Letizia Gnetti, Andrea Alimonti, Hermeto Gerber, Mitko Dimitrov, Ajinkya Revandkar, Maria Luna Perciato, Sandra Pinton, Nicolas Delaleu, Andrea Rinaldi, Marco Losa, Patrick C. Fraering, Emiliano Pasquini, Francesco Bertoni, Alain Nepveu, Alberto Toso, Rocco D'Antuono, Jingjing Chen
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-12 (2016)
Nature communications, vol. 7, pp. 13719
Nature Communications
Nature Communications, 7 (1)
Nature communications, vol. 7, pp. 13719
Nature Communications
Nature Communications, 7 (1)
Activation of NOTCH signalling is associated with advanced prostate cancer and treatment resistance in prostate cancer patients. However, the mechanism that drives NOTCH activation in prostate cancer remains still elusive. Moreover, preclinical evide
Autor:
Séverine Mazaud Guittot, Sandra Fontanière, Alain Calender, Nader Hussein, Anne-Marie Morera, Nathalie di Clemente, Huguette Casse, Jieli Lu, Chang X. Zhang
Publikováno v:
Endocrine-Related Cancer
Endocrine-Related Cancer, BioScientifica, 2008, 15 (1), pp. 217-27. ⟨10.1677/ERC-06-0046⟩
Endocrine-Related Cancer, BioScientifica, 2008, 15 (1), pp. 217-27. ⟨10.1677/ERC-06-0046⟩
International audience; Multiple endocrine neoplasia type 1 (MEN1) results from the mutation of the predisposing gene, MEN1. Heterozygous Men1 mutant mice previously generated by several laboratories, including ours, mimic largely MEN1 pathology. Int
Publikováno v:
Cell Death and Differentiation
Cell Death and Differentiation, Nature Publishing Group, 2009, 16 (9), pp.1227--37. ⟨10.1038/cdd.2009.38⟩
Cell Death and Differentiation, Nature Publishing Group, 2009, 16 (9), pp.1227--37. ⟨10.1038/cdd.2009.38⟩
The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has gained much attention as a possible therapeutic reagent for the treatment of tumors, as TRAIL was originally described to induce apoptosis specifically in cancer cells, but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9104f0b2262fb56689993e62258b7993
https://hal.archives-ouvertes.fr/hal-02194088
https://hal.archives-ouvertes.fr/hal-02194088
Autor:
Jean-Charles Sanchez, Fernando J. Corrales, Anna Greco, Alberto L. Epstein, Enrique Santamaría, Loïc Dayon, Virginia Sánchez-Quiles, Maria Giovanna Foschini, María I. Mora, Victor Segura, Jesús Prieto
Publikováno v:
Molecular and Cellular Proteomics, Vol. 10, No 6 (2011) P. M111.009126
Herpesvirus type 1 (HSV-1) based oncolytic vectors arise as a promising therapeutic alternative for neoplastic diseases including hepatocellular carcinoma. However, the mechanisms mediating the host cell response to such treatments are not completely